Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.57 |
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | MGLL | Q99685 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.50 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.47 |
| ▸ | AR | P10275 | 2/20 | 0.47 |
| ▸ | PGR | P06401 | 1/20 | 0.47 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17326723 | 0.90 | KDM4E (0.57) | ESR1FAAHMGLLNPC1RAB9A | |
| SCHEMBL3477804 | 0.89 | ESR1 (0.64) | ESR1POLBCTDSP1NR1H3AR | |
| SCHEMBL7360727 | 0.89 | ESR1 (0.77) | ESR1NPC1RAB9APOLBCTDSP1 | |
| SCHEMBL17326263 | 0.89 | MAPK1 (0.59) | ESR1MGLLNPC1RAB9AAR | |
| SCHEMBL1734116 | 0.86 | ESR1 (0.58) | ESR1MGLLNPC1RAB9APOLB | |
| SCHEMBL17326658 | 0.86 | MGLL (0.54) | ESR1MGLLNR1H3ARALDH1A1 | |
| SCHEMBL17326262 | 0.85 | KMT2A (0.60) | RAB9APOLBCTDSP1MAPK1ALDH1A1 | |
| SCHEMBL7400864 | 0.83 | PGR (0.63) | ESR1FAAHMGLLPOLBCTDSP1 | |
| SCHEMBL13265371 | 0.80 | ALDH1A1 (0.65) | ESR1NPC1RAB9APOLBAR | |
| SCHEMBL725608 | 0.80 | NR1H3 (0.67) | ESR1FAAHMGLLNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2162457-B1 | CARBAZOLYL POLYMERS FOR ORGANIC ELECTRONIC DEVICES | BOE TECHNOLOGY GROUP CO LTD (CN) | 2018-08-22 | — | — | EP | disclosed |
| EP-2102160-B1 | CARBAZOLYL MONOMERS AND POLYMERS | GEN ELECTRIC (US) | 2011-11-16 | — | — | EP | disclosed |
| US-20110262920-A1 | METHODS FOR PREDICTING SURVIVAL IN CANCER PATIENTS | CITY OF HOPE | 2011-10-27 | — | — | US | disclosed |
| EP-2102159-B1 | BIS-CARBAZOLE MONOMERS AND POLYMERS | GEN ELECTRIC (US) | 2011-06-22 | — | — | EP | disclosed |
| US-7851579-B2 | Monomers comprising carbazole units and polymers, dendrimers, and hyper-branched materials derived therefrom; OLEDs having device quantum efficiencies, while still maintaining the potential for the molecules to host red, green, and blue emissive complexes | GENERAL ELECTRIC COMPANY (US) | 2010-12-14 | — | — | US | disclosed |
| EP-2162457-A2 | CARBAZOLYL POLYMERS FOR ORGANIC ELECTRONIC DEVICES | General Electric Company (US) | 2010-03-17 | — | — | EP | disclosed |
| US-7635777-B2 | Carbazolyl monomers and polymers | GENERAL ELECTRIC COMPANY (US) | 2009-12-22 | — | — | US | disclosed |
| EP-2102160-A1 | CARBAZOLYL MONOMERS AND POLYMERS | GENERAL ELECTRIC COMPANY (US) | 2009-09-23 | — | — | EP | disclosed |
| EP-2102159-A1 | BIS-CARBAZOLE MONOMERS AND POLYMERS | GENERAL ELECTRIC COMPANY (US) | 2009-09-23 | — | — | EP | disclosed |
| WO-2009023335-A2 | CARBAZOLYL POLYMERS FOR ORGANIC ELECTRONIC DEVICES | GENERAL ELECTRIC COMPANY (US) | 2009-02-19 | — | — | WO | disclosed |
| WO-2008076569-A1 | BIS-CARBAZOLE MONOMERS AND POLYMERS | GENERAL ELECTRIC COMPANY (US) | 2008-06-26 | — | — | WO | disclosed |
| WO-2008073694-A1 | CARBAZOLYL MONOMERS AND POLYMERS | GENERAL ELECTRIC COMPANY (US) | 2008-06-19 | — | — | WO | disclosed |
| US-20080145665-A1 | polyesters, polyethers, polycarbonates, polyestercarbonates, polyetherketones, or polyethersulfones for use in organic light emitters; quantum efficiencies | GENERAL ELECTRIC COMPANY (US) | 2008-06-19 | — | — | US | disclosed |
| US-20080138625-A1 | CARBAZOLYL MONOMERS AND POLYMERS | GENERAL ELECTRIC COMPANY (US) | 2008-06-12 | — | — | US | disclosed |
| US-20080135806-A1 | CARBAZOLYL POLYMERS FOR ORGANIC ELECTRONIC DEVICES | GENERAL ELECTRIC COMPANY (US) | 2008-06-12 | — | — | US | disclosed |
| US-7381985-B1 | Bis-carbazole monomers and polymers | GENERAL ELECTRIC COMPANY (US) | 2008-06-03 | — | — | US | disclosed |
| EP-0816414-A2 | Preparation of polyether polymers | GENERAL ELECTRIC COMPANY (US) | 1998-01-07 | — | — | EP | disclosed |
| US-5663275-A | POLYETHERIMIDES, HIGH MOLECULAR WEIGHT, ENGINEERING RESINS | GENERAL ELECTRIC COMPANY (US) | 1997-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080138625-A1 | CARBAZOLYL MONOMERS AND POLYMERS | CBR3, C1S, C3AR1 | ESR1 1884/4885FAAH 1617/4885MGLL 3311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.